Jessica A Kahn1, Bret J Rudy, Jiahong Xu, Elizabeth A Secord, Bill G Kapogiannis, Sarah Thornton, Maura L Gillison. 1. From the *Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH; †New York University School of Medicine, New York, NY; ‡Westat, Rockville, MD; §Wayne State University, Detroit, MI; ¶Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD; and ∥Ohio State University, Columbus, OH.
Abstract
BACKGROUND: Little is known about the epidemiology or risk factors for oral human papillomavirus (HPV) in HIV-infected youth. The objectives of this study were to determine the prevalence and correlates of oral HPV infection and to explore the association between HPV vaccination and oral infection in HIV-infected youth. METHODS: Youth 12 to 24 years of age with behaviorally acquired HIV were recruited for this cross-sectional study. Procedures involved medical chart review, survey, and collection of an oral rinse sample. Univariable and multivariable logistic regression models were used to determine whether demographic, behavioral, immunologic, and virologic factors and history of vaccination were significantly associated with oral HPV infection. RESULTS: Mean age of the 272 participants was 21.5 years; 64% were non-Hispanic black and 20.2% were Hispanic; and 10.8% of men compared with 20.3% of women were fully vaccinated. Human papillomavirus prevalence was 19.7% in men and 18.6% in women (P = 1.0). Only men were positive for vaccine-type HPV: 5.6% were positive for HPV-6, HPV-11, HPV-16, and/or HPV-18, and 4.2% were positive for HPV-16 and/or HPV-18. Among men who were fully vaccinated, none were positive for HPV-6, HPV-11, HPV-16, and/or HPV-18, compared with 12 (6.3%) of men who were not fully vaccinated (P = 0.37). Two variables were marginally associated with oral HPV (P < 0.10): marijuana use in the previous 3 months and lower CD4+ T-cell count. CONCLUSIONS: Prevalence rates of oral HPV were relatively high in this population of HIV-infected youth and were similar in male and female youth. No fully vaccinated men were infected with vaccine-type HPV.
BACKGROUND: Little is known about the epidemiology or risk factors for oral human papillomavirus (HPV) in HIV-infected youth. The objectives of this study were to determine the prevalence and correlates of oral HPV infection and to explore the association between HPV vaccination and oral infection in HIV-infected youth. METHODS: Youth 12 to 24 years of age with behaviorally acquired HIV were recruited for this cross-sectional study. Procedures involved medical chart review, survey, and collection of an oral rinse sample. Univariable and multivariable logistic regression models were used to determine whether demographic, behavioral, immunologic, and virologic factors and history of vaccination were significantly associated with oral HPV infection. RESULTS: Mean age of the 272 participants was 21.5 years; 64% were non-Hispanic black and 20.2% were Hispanic; and 10.8% of men compared with 20.3% of women were fully vaccinated. Human papillomavirus prevalence was 19.7% in men and 18.6% in women (P = 1.0). Only men were positive for vaccine-type HPV: 5.6% were positive for HPV-6, HPV-11, HPV-16, and/or HPV-18, and 4.2% were positive for HPV-16 and/or HPV-18. Among men who were fully vaccinated, none were positive for HPV-6, HPV-11, HPV-16, and/or HPV-18, compared with 12 (6.3%) of men who were not fully vaccinated (P = 0.37). Two variables were marginally associated with oral HPV (P < 0.10): marijuana use in the previous 3 months and lower CD4+ T-cell count. CONCLUSIONS: Prevalence rates of oral HPV were relatively high in this population of HIV-infected youth and were similar in male and female youth. No fully vaccinated men were infected with vaccine-type HPV.
Authors: Aimee R Kreimer; Alessandro Villa; Alan G Nyitray; Martha Abrahamsen; Mary Papenfuss; Danelle Smith; Allan Hildesheim; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-12-10 Impact factor: 4.254
Authors: Elaine M Smith; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek Journal: Cancer Causes Control Date: 2010-04-17 Impact factor: 2.506
Authors: Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer Journal: N Engl J Med Date: 2003-02-06 Impact factor: 91.245
Authors: Rolando Herrero; Xavier Castellsagué; Michael Pawlita; Jolanta Lissowska; Frank Kee; Prabda Balaram; Thangarajan Rajkumar; Hema Sridhar; Barbara Rose; Javier Pintos; Leticia Fernández; Ali Idris; María José Sánchez; Adoración Nieto; Renato Talamini; Alessandra Tavani; F Xavier Bosch; Ulrich Reidel; Peter J F Snijders; Chris J L M Meijer; Raphael Viscidi; Nubia Muñoz; Silvia Franceschi Journal: J Natl Cancer Inst Date: 2003-12-03 Impact factor: 13.506
Authors: Elaine M Smith; Justine M Ritchie; Jerome Yankowitz; Sandhya Swarnavel; Donghong Wang; Thomas H Haugen; Lubomir P Turek Journal: Sex Transm Dis Date: 2004-01 Impact factor: 2.830
Authors: Rolando Herrero; Wim Quint; Allan Hildesheim; Paula Gonzalez; Linda Struijk; Hormuzd A Katki; Carolina Porras; Mark Schiffman; Ana Cecilia Rodriguez; Diane Solomon; Silvia Jimenez; John T Schiller; Douglas R Lowy; Leen-Jan van Doorn; Sholom Wacholder; Aimée R Kreimer Journal: PLoS One Date: 2013-07-17 Impact factor: 3.240
Authors: S S Wang; M Schiffman; R Herrero; J Carreon; A Hildesheim; A C Rodriguez; M C Bratti; M E Sherman; J Morales; D Guillen; M Alfaro; B Clayman; R D Burk; R P Viscidi Journal: Br J Cancer Date: 2004-10-04 Impact factor: 7.640
Authors: Anna-Barbara Moscicki; Sepideh Farhat; Tzy-Jyun Yao; Mark I Ryder; Jonathan S Russell; Russell B Van Dyke; Rohan Hazra; Caroline H Shiboski Journal: Sex Transm Dis Date: 2016-08 Impact factor: 2.830
Authors: Thomas Harder; Ole Wichmann; Stefanie J Klug; Marianne A B van der Sande; Miriam Wiese-Posselt Journal: BMC Med Date: 2018-07-18 Impact factor: 8.775